209 related articles for article (PubMed ID: 3129897)
1. Effect of poly I:C-activated peritoneal cells on the take of transplantable murine tumours.
Minárovits J; Karczag E; Földes I
Acta Microbiol Hung; 1987; 34(3-4):197-205. PubMed ID: 3129897
[TBL] [Abstract][Full Text] [Related]
2. Mouse peritoneal cells activated with a combination of indomethacin, poly I:C and Syncumar inhibit the take of Lewis lung carcinoma in adoptive transfer assay.
Karczag E; Minárovits J; Földes I
Acta Microbiol Hung; 1987; 34(3-4):207-14. PubMed ID: 3448880
[TBL] [Abstract][Full Text] [Related]
3. Characterization of activated peritoneal cells inhibiting the take of transplantable murine tumours.
Minárovits J; Karczag E; Földes I
Acta Microbiol Hung; 1989; 36(1):33-9. PubMed ID: 2603645
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of peritoneal and spleen cells of syngeneic or allogeneic origin on the take of transplantable murine tumours.
Karczag E; Minárovits J; Földes I
Acta Microbiol Hung; 1989; 36(1):25-31. PubMed ID: 2603643
[TBL] [Abstract][Full Text] [Related]
5. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
Gabizon A; Leibovich SJ; Goldman R
J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
[TBL] [Abstract][Full Text] [Related]
6. Environmental conditions favorable for tumor progression in peritoneal cavity induced by peritoneal cells without tumor selectivity.
Segawa K; Ueno Y; Kataoka T
Jpn J Exp Med; 1989 Jun; 59(3):127-33. PubMed ID: 2681889
[TBL] [Abstract][Full Text] [Related]
7. Enhanced take of spontaneous murine tumors in mice treated with inhibitors of macrophage and/or NK cell function.
Minarovits J; Karczag E; Földes I
Neoplasma; 1989; 36(1):3-9. PubMed ID: 2704423
[TBL] [Abstract][Full Text] [Related]
8. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
Taramelli D; Varesio L
J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
[TBL] [Abstract][Full Text] [Related]
9. Distribution of peritoneal macrophage populations after intravenous injection in mice: differential effects of eliciting and activating agents.
Wiltrout RH; Brunda MJ; Gorelik E; Peterson ES; Dunn JJ; Leonhardt J; Varesio L; Reynolds CW; Holden HT
J Reticuloendothel Soc; 1983 Sep; 34(3):253-69. PubMed ID: 6620256
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
Hanna N; Schneider M
J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
[TBL] [Abstract][Full Text] [Related]
11. Inducible macrophage cytotoxins. I. Biokinetics of activation and release in vitro.
Reidarson TH; Levy WE; Klostergaard J; Granger GA
J Natl Cancer Inst; 1982 Oct; 69(4):879-87. PubMed ID: 6956764
[TBL] [Abstract][Full Text] [Related]
12. Effect of peritoneal cells on tumors cells growth in vitro.
Salwa J
Arch Immunol Ther Exp (Warsz); 1995; 43(1):37-41. PubMed ID: 8744682
[TBL] [Abstract][Full Text] [Related]
13. Macrophage processing of antigen for induction of tumor immunity.
Brunda MJ; Raffel S
Cancer Res; 1977 Jun; 37(6):1838-44. PubMed ID: 66987
[TBL] [Abstract][Full Text] [Related]
14. Interferon-inducibility is diminished in tumour-bearing mice.
Hung PL; Stöger I; Karczag E; Minárovics J; Földes I
Acta Microbiol Hung; 1989; 36(4):433-8. PubMed ID: 2484273
[TBL] [Abstract][Full Text] [Related]
15. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of cancer: experimental approach with activated macrophages proliferating in culture.
Bartholeyns J; Lombard Y; Dumont S; Hartmann D; Chokry M; Giaimis J; Kaufmann S; Poindron P
Cancer Detect Prev; 1988; 12(1-6):413-20. PubMed ID: 3180139
[TBL] [Abstract][Full Text] [Related]
17. Comparison of some properties of normal or stimulated murine peritoneal macrophages.
Fornůsek L; Vĕtvicka V
Folia Biol (Praha); 1984; 30(1):67-79. PubMed ID: 6714482
[TBL] [Abstract][Full Text] [Related]
18. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
19. A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions.
Giovarelli M; Musiani P; Garotta G; Ebner R; Di Carlo E; Kim Y; Cappello P; Rigamonti L; Bernabei P; Novelli F; Modesti A; Coletti A; Ferrie AK; Lollini PL; Ruben S; Salcedo T; Forni G
J Immunol; 1999 Nov; 163(9):4886-93. PubMed ID: 10528190
[TBL] [Abstract][Full Text] [Related]
20. Cell surface changes in mouse peritoneal macrophages after induction with proteose peptone or thioglycollate.
Vĕtvicka V; Viklický V; Zelený V
Folia Biol (Praha); 1979; 25(3):156-68. PubMed ID: 114430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
